During a live event, Mojtaba Akhtari, MD, discussed trials studying patients with high-risk polycythemia vera.

Israel: A new study published in JAMA Network Open highlights a key safety insight for patients with type 2 diabetes taking ...

Q: I’m having some memory problems, and my doctor said to eat more salads. What does that have to do with anything? — Pat R., ...

Dr. Soma Mandal, a board-certified internist at Summit Health in New Providence, New Jersey, says that getting a CBC test is ...

FLT3-ITD MRD dynamics predicted relapse risk and shaped response to gilteritinib maintenance in post-transplant AML.

Catch up with the most important stories from around Europe and beyond - latest news, breaking news, World, Business, ...

Understanding how and why this happens is important not just for those with diabetes, but also for those at risk.

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell ...

Rusfertide is an investigational, first-in-class hepcidin mimetic peptide therapeutic that aims to regulate iron homeostasis ...

Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Funding to support MOCART, a ...

A high-throughput workflow for wide-targeted metabolomics in dried blood spots (DBS) is presented.

The Iranian Foreign Minister Abbas Araghchi has condemned US strikes on the country’s nuclear facilities. He said Iran continues to defend itself by all means necessary against US and Israeli military ...